Assessing the Yield and Safety of Endoscopy in Acute Graft--host Disease After Hematopoietic Stem Cell Transplant

Overview

Journal World J Gastrointest Endosc

Publisher Baishideng Publishing Group

Date 2020 Nov 2

PMID 33133371

Citations 1

Authors

Anand V Rajan

Harry Trieu

Peiguo Chu

James Lin

Trilokesh Dey Kidambi

Affiliations

Soon will be listed here.

Abstract

Background: Acute gastrointestinal (GI) graft--host disease (aGVHD) is the most complication of hematopoietic stem cell transplant (HSCT) in patients with hematologic malignancy. Limited data exists on endoscopic evaluation of GVHD in post-HSCT patients with differing GI symptoms. Further, the diagnostic value of gross endoscopic findings as well as the safety of endoscopy in this commonly thrombocytopenic and neutropenic patient population remains unclear.

Aim: To understand the diagnostic value of symptoms and gross endoscopic findings as well as safety of endoscopy in aGVHD patients.

Methods: We analyzed 195 endoscopies performed at City of Hope in patients who underwent allogeneic HSCT less than 100 d prior for hematologic malignancy and were subsequently evaluated for aGVHD endoscopy. The yield, sensitivity, and specificity of diagnosing aGVHD were calculated for upper and lower endoscopy, various GI tract locations, and presenting symptoms.

Results: Combined esophagogastroduodenoscopy (EGD) and flexible sigmoidoscopy (FS) demonstrated a greater diagnostic yield for aGVHD (83.1%) compared to EGD (66.7%) or FS (77.2%) alone with any presenting symptom. The upper and lower GI tract demonstrated similar yields regardless of whether patients presented with diarrhea (95.7% 99.1%) or nausea/vomiting (97.5% 96.8%). Normal-appearing mucosa was generally as specific (91.3%) as abnormal mucosa (58.7%-97.8%) for the presence of aGVHD. Adverse events such as bleeding (1.0%), infection (1.0%), and perforation (0.5%) only occurred in a small proportion of patients, with no significant differences in those with underlying thrombocytopenia ( = 1.000) and neutropenia ( = 0.425).

Conclusion: Combined EGD and FS with biopsies of normal and inflamed mucosa demonstrated the greatest diagnostic yield regardless of presenting symptom and appears to be safe in this population of patients.

Citing Articles

Role of Endoscopic Techniques in the Diagnosis of Complications of Allogeneic Hematopoietic Stem Cell Transplantation: A Review of the Literature.

Bangolo A, Dey S, Nagesh V, Gumer K, Avetisyan L, Islam S J Clin Med. 2024; 13(15).

PMID: 39124609 PMC: 11313381. DOI: 10.3390/jcm13154343.

References

Zeiser R, Blazar B . Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N Engl J Med. 2017; 377(22):2167-2179. PMC: 6034180. DOI: 10.1056/NEJMra1609337. View

Terdiman J, Linker C, Ries C, Damon L, Rugo H, Ostroff J . The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation. Endoscopy. 1996; 28(8):680-5. DOI: 10.1055/s-2007-1005576. View

Rowlings P, Przepiorka D, Klein J, Gale R, Passweg J, Henslee-Downey P . IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997; 97(4):855-64. DOI: 10.1046/j.1365-2141.1997.1112925.x. View

Nomura K, Iizuka T, Kaji D, Yamamoto H, Kuribayashi Y, Tanaka M . Utility of Endoscopic Examination in the Diagnosis of Acute Graft-versus-Host Disease in the Lower Gastrointestinal Tract. Gastroenterol Res Pract. 2017; 2017:2145986. PMC: 5688249. DOI: 10.1155/2017/2145986. View

Lee S . Classification systems for chronic graft-versus-host disease. Blood. 2016; 129(1):30-37. PMC: 5216262. DOI: 10.1182/blood-2016-07-686642. View

Cruz-Correa M, Poonawala A, Abraham S, Wu T, Zahurak M, Vogelsang G . Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease. Endoscopy. 2002; 34(10):808-13. DOI: 10.1055/s-2002-34257. View

Shulman H, Cardona D, Greenson J, Hingorani S, Horn T, Huber E . NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015; 21(4):589-603. PMC: 4359636. DOI: 10.1016/j.bbmt.2014.12.031. View

Kreisel W, Dahlberg M, Bertz H, Harder J, Potthoff K, Deibert P . Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant. 2011; 47(3):430-8. PMC: 3296915. DOI: 10.1038/bmt.2011.137. View

Sung A, Hassan S, Cardona D, Wild D, Nichols K, Mehdikhani H . Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults. Biol Blood Marrow Transplant. 2017; 24(4):734-740. PMC: 6415754. DOI: 10.1016/j.bbmt.2017.12.772. View

10.

Oh H, Park J, Yoon S, Lee H, Lim C, Kim J . Bleeding After Endoscopic Procedures in Patients With Chronic Hematologic Thrombocytopenia. Dig Dis Sci. 2016; 62(3):746-754. DOI: 10.1007/s10620-016-4427-4. View

11.

Cheung D, Kim J, Kim S, Sung H, Cho S, Park S . Endoscopic evaluation in gastrointestinal graft-versus-host disease: comparisons with histological findings. Dig Dis Sci. 2008; 53(11):2947-54. DOI: 10.1007/s10620-008-0262-6. View

12.

Xu C, Zhu L, Xu X, Chen W, Wu D . Endoscopic diagnosis of gastrointestinal graft-versus-host disease. World J Gastroenterol. 2008; 14(14):2262-7. PMC: 2703857. DOI: 10.3748/wjg.14.2262. View

13.

Ross W . Endoscopic Interventions in Patients with Thrombocytopenia. Gastroenterol Hepatol (N Y). 2016; 11(2):115-7. PMC: 4836569. View

14.

Liu A, Meyer E, Johnston L, Brown J, Gerson L . Prevalence of graft versus host disease and cytomegalovirus infection in patients post-haematopoietic cell transplantation presenting with gastrointestinal symptoms. Aliment Pharmacol Ther. 2013; 38(8):955-66. DOI: 10.1111/apt.12468. View

15.

Krishna S, Rao B, Thirumurthi S, Lee J, Ramireddy S, Guindani M . Safety of endoscopic interventions in patients with thrombocytopenia. Gastrointest Endosc. 2014; 80(3):425-34. DOI: 10.1016/j.gie.2014.02.023. View

16.

Daniel F, Hassoun L, Husni M, Sharara A, Soweid A, Barada K . Site specific diagnostic yield of endoscopic biopsies in Gastrointestinal Graft-versus-Host Disease: A tertiary care Center experience. Curr Res Transl Med. 2018; 67(1):16-19. DOI: 10.1016/j.retram.2018.08.001. View

17.

Ross W, Ghosh S, Dekovich A, Liu S, Ayers G, Cleary K . Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies. Am J Gastroenterol. 2007; 103(4):982-9. DOI: 10.1111/j.1572-0241.2007.01639.x. View

18.

Altun R, Gokmen A, Tek I, Soydan E, Kurt Yuksel M . Endoscopic evaluation of acute intestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Turk J Gastroenterol. 2016; 27(4):312-6. DOI: 10.5152/tjg.2016.15353. View

19.

Ben-Menachem T, Decker G, Early D, Evans J, Fanelli R, Fisher D . Adverse events of upper GI endoscopy. Gastrointest Endosc. 2012; 76(4):707-18. DOI: 10.1016/j.gie.2012.03.252. View

20.

Van Os E, Kamath P, Gostout C, Heit J . Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc. 1999; 50(4):536-43. DOI: 10.1016/s0016-5107(99)70079-9. View